⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5217974 | 0.92 | — | — | |
| SCHEMBL3785 | 0.82 | — | — | |
| SCHEMBL1780497 | 0.71 | — | — | |
| SCHEMBL1743454 | 0.65 | — | — | |
| SCHEMBL7564231 | 0.57 | — | — | |
| Cyclopentene SCHEMBL23360768 | 0.55 | — | — | |
| Cyclohexene SCHEMBL20578013 | 0.55 | — | — | |
| Cyclohexene SCHEMBL28954677 | 0.55 | ALDH1A1 (0.30) | — | |
| Cyclooctene SCHEMBL29195402 | 0.52 | — | — | |
| Methane SCHEMBL28326973 | 0.52 | HDAC3 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2726107-A1 | POLYMER PARTICLES OR NANO-VECTORS AND USE THEREOF AS A DRUG AND/OR DIAGNOSTIC AGENT | Centre National De La Recherche Scientifique (FR) | 2014-05-07 | — | — | EP | claimed |
| US-8349857-B2 | Quinazoline derivatives having tyrosine kinase inhibitory activity | SHIONOGI & CO., LTD. (JP) | 2013-01-08 | — | — | US | claimed |
| WO-2013001244-A1 | POLYMER PARTICLES OR NANO-VECTORS AND USE THEREOF AS A DRUG AND/OR DIAGNOSTIC AGENT | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-03 | — | — | WO | claimed |
| EP-1771492-B1 | STIMULATEABLE POLYMER PARTICLES EXHIBITING REACTIVE FUNCTIONS, METHOD FOR THE PRODUCTION AND THE USE THEREOF | CENTRE NAT RECH SCIENT (FR) | 2010-11-10 | — | — | EP | claimed |
| EP-1758621-B1 | BIOACTIVE BIOMATERIALS FOR CONTROLLED DELIVERY OF ACTIVE PRINCIPLES | CENTRE NAT RECH SCIENT (FR) | 2010-08-11 | — | — | EP | claimed |
| EP-1771492-A1 | STIMULATEABLE POLYMER PARTICLES EXHIBITING REACTIVE FUNCTIONS, METHOD FOR THE PRODUCTION AND THE USE THEREOF | Centre National De La Recherche Scientifique (FR) | 2007-04-11 | — | — | EP | claimed |
| EP-1758621-A1 | BIOACTIVE BIOMATERIALS FOR CONTROLLED DELIVERY OF ACTIVE PRINCIPLES | The Centre National de la Recherche Scientifique (FR) | 2007-03-07 | — | — | EP | claimed |
| WO-2006008387-A1 | STIMULATEABLE POLYMER PARTICLES EXHIBITING REACTIVE FUNCTIONS, METHOD FOR THE PRODUCTION AND THE USE THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-01-26 | — | — | WO | claimed |
| WO-2006008386-A1 | BIOACTIVE BIOMATERIALS FOR CONTROLLED DELIVERY OF ACTIVE PRINCIPLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-01-26 | — | — | WO | claimed |
| EP-4396163-A1 | HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS | BASF SE (DE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396173-A1 | HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM | BASF SE (DE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4375274-A1 | ANNULATED PYRIDAZINE COMPOUND | Nico Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024100115-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024084448-A2 | FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS | DONG-A ST CO., LTD. (KR) | 2024-04-25 | — | — | WO | disclosed |
| EP-0882703-B1 | CYCLIC AMIC ACID DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2002-08-14 | — | — | EP | disclosed |
| EP-0882701-B1 | SUBSTITUTED AMIDE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2002-07-24 | — | — | EP | disclosed |
| US-6048894-A | FARNESYL-PROTEIN TRANSFERASE INHIBITORS, ANTITUMOR OR ANTICANCER AGENTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-04-11 | — | — | US | disclosed |
| US-6011174-A | INHIBIT PROTEIN-FARNESYL TRANSFERASE (PFT) IN VIVO THEREBY TO SUPPRESS FUNCTION OF ONCOGENE PROTEIN RAS AND THUS PRESENT ANTITUMOR ACTIVITIES, | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-01-04 | — | — | US | disclosed |
| EP-0882703-A1 | CYCLIC AMIC ACID DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0882701-A1 | SUBSTITUTED AMIDE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |